PL1845957T3 - Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben - Google Patents

Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben

Info

Publication number
PL1845957T3
PL1845957T3 PL06723000T PL06723000T PL1845957T3 PL 1845957 T3 PL1845957 T3 PL 1845957T3 PL 06723000 T PL06723000 T PL 06723000T PL 06723000 T PL06723000 T PL 06723000T PL 1845957 T3 PL1845957 T3 PL 1845957T3
Authority
PL
Poland
Prior art keywords
producing
hydroxystilbenes
drug extract
drug
pharmaceutical
Prior art date
Application number
PL06723000T
Other languages
English (en)
Inventor
Peter Heger
Reinhard Rettenberger
Carl-Friedrich Spaich
Original Assignee
Peter Heger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Heger filed Critical Peter Heger
Publication of PL1845957T3 publication Critical patent/PL1845957T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482Cassia, e.g. golden shower tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL06723000T 2005-02-04 2006-02-03 Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben PL1845957T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102005005268 2005-02-04
DE102005005271 2005-02-04
EP20060723000 EP1845957B1 (de) 2005-02-04 2006-02-03 Verfahren zur herstellung eines hydroxystilben-haltigen drogenextraktes
PCT/EP2006/000955 WO2006082071A1 (de) 2005-02-04 2006-02-03 Verfahren zur herstellung eines hydroxystilben-haltigen drogenextraktes

Publications (1)

Publication Number Publication Date
PL1845957T3 true PL1845957T3 (pl) 2011-07-29

Family

ID=36190656

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06723000T PL1845957T3 (pl) 2005-02-04 2006-02-03 Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben

Country Status (9)

Country Link
US (4) US8168220B2 (pl)
EP (2) EP1843745A1 (pl)
AT (1) ATE492271T1 (pl)
AU (2) AU2006210117B2 (pl)
CA (2) CA2596189C (pl)
DE (1) DE502006008551D1 (pl)
PL (1) PL1845957T3 (pl)
RU (3) RU2007132962A (pl)
WO (2) WO2006082071A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1845957T3 (pl) * 2005-02-04 2011-07-29 Peter Heger Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben
WO2006082068A1 (de) 2005-02-04 2006-08-10 Peter Heger Verwendung einer hydroxystilben-haltigen wirkstoffkombination zur prävention und/oder behandlung von krankheiten
EP1972343B1 (de) * 2007-03-23 2011-01-12 Navalis Nutraceuticals GmbH Arzneimittel enthaltend Fraumenmantel zur Behandlung von Endometritis, Vaginitis
FR2922768B1 (fr) * 2007-10-25 2010-01-22 Vetoquinol Sa Procede pour masquer l'amertume d'un extrait sec vegetal de rhubarbe
EP2085077A1 (en) * 2008-01-30 2009-08-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Coating compositions for controlled relaease formulations
CN102220387B (zh) * 2011-04-12 2013-02-06 安康中科麦迪森天然药业有限公司 一种从新鲜虎杖中提取纯化白藜芦醇和大黄素的方法
CN102659861B (zh) * 2012-04-18 2015-06-17 昆药集团股份有限公司 一种曲札茋苷的纯化方法
CN102702283B (zh) * 2012-05-08 2014-08-13 青海伊纳维康生物科技有限公司 一种快速分离制备高纯度脱氧土大黄苷和土大黄苷的方法
CN102908410A (zh) * 2012-11-20 2013-02-06 青海伊纳维康生物科技有限公司 一种治疗骨质疏松症和更年期综合症的大黄提取物
CN103070849B (zh) * 2013-01-29 2014-06-04 江苏省中国科学院植物研究所 氧化白藜芦醇在制备抗卵巢衰老药物中的应用
CN103181958A (zh) * 2013-03-21 2013-07-03 河北科技师范学院 治疗奶牛子宫内膜炎的中草药灌注液及其制备方法
CN104605160B (zh) * 2015-01-20 2016-08-17 湖南农业大学 一种防治母猪产后子宫内膜炎的组合物及其应用
CN110227106A (zh) * 2019-05-28 2019-09-13 河南利联科技有限公司 一种治疗痛经的中药组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ181274A (en) 1976-06-24 1979-12-11 New Zealand Forest Prod Extraction of phenolic compounds from bark;adhesives;building boards
DE9414066U1 (de) 1994-08-31 1994-11-03 Roehm Gmbh Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
WO1997044407A1 (en) 1996-05-23 1997-11-27 Ian Alexander Gilmour Process for extraction of proanthocyanidins from botanical material
US6414037B1 (en) 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
US6197834B1 (en) * 1998-09-01 2001-03-06 Northeastern Ohio Universities College Of Medicine Method of inhibiting formation of infectious herpes virus particles
US6361815B1 (en) 1998-12-21 2002-03-26 Pure World Botanicals, Inc. Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
EP1161944B1 (en) 1999-01-29 2006-09-20 Sunstar Inc. Drugs, foods and oral compositions containing stilbene-type compounds
IT1312377B1 (it) * 1999-03-05 2002-04-15 Uni Ci S R L Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
PE20010540A1 (es) * 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
WO2001021165A1 (en) 1999-09-21 2001-03-29 Rutgers, The State University Resveratrol analogs for prevention of disease
CN101810600B (zh) * 2001-11-02 2012-11-21 加州大学校务委员会 用于预防和治疗炎性疾病,自体免疫性疾病,和移植排斥的组成物及方法
FR2835185B1 (fr) * 2002-01-30 2004-04-02 Berkem Sa Extrait de rhubarbe, compositions obtenues a partir dudit extrait, procede d'obtention et utilisations
US20080026086A1 (en) * 2004-01-07 2008-01-31 Caroline Dawn Holyoak Synergistic Neuroprotective, Combinations Of Flavanols, Hydroxystilbenes, Flavanones, Flavones, Flavonols, Proanthocyanidins And Anthocyanidins
WO2006082072A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von hydroxystilben-haltigen wirkstoffen zur prävention und/oder behandlung von osteoporose
WO2006082068A1 (de) 2005-02-04 2006-08-10 Peter Heger Verwendung einer hydroxystilben-haltigen wirkstoffkombination zur prävention und/oder behandlung von krankheiten
PL1845957T3 (pl) * 2005-02-04 2011-07-29 Peter Heger Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben

Also Published As

Publication number Publication date
WO2006082071A1 (de) 2006-08-10
RU2007132962A (ru) 2009-03-10
AU2006210117A1 (en) 2006-08-10
ATE492271T1 (de) 2011-01-15
AU2006210119B2 (en) 2011-09-22
EP1843745A1 (de) 2007-10-17
WO2006082073A1 (de) 2006-08-10
CA2596178C (en) 2013-10-08
AU2006210117B2 (en) 2011-07-21
EP1845957B1 (de) 2010-12-22
CA2596189C (en) 2014-12-16
US20140099368A1 (en) 2014-04-10
CA2596178A1 (en) 2006-08-10
RU2007132964A (ru) 2009-03-10
DE502006008551D1 (de) 2011-02-03
US20120195942A1 (en) 2012-08-02
US9125857B2 (en) 2015-09-08
US20080248069A1 (en) 2008-10-09
RU2007132963A (ru) 2009-03-10
EP1845957A1 (de) 2007-10-24
AU2006210119A1 (en) 2006-08-10
US8168220B2 (en) 2012-05-01
CA2596189A1 (en) 2006-08-10
US20090048184A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
PL1845957T3 (pl) Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben
MY146247A (en) Solid pharmaceutical dosage form comprising ritonavir
CL2008001002A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008000369A1 (es) Compuestos derivados de piridopirimidinonas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dolor, depresion, enfermedades cardiovasculares, enfermedades respiratorias y enfermedades psiquiatricas.
CL2007002446A1 (es) Compuestos derivados de morfolino pirimidina; composicion farmaceutica; y su uso para preparar un medicamento para producir un efecto antiproliferante.
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
TW200716646A (en) (S)-N-methylnaltrexone
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
ECSP10010295A (es) Formulacion de anticuerpo
PA8770101A1 (es) Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
CL2008000691A1 (es) Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades.
WO2009121039A3 (en) Administration of benzodiazepine compositions
MX343358B (es) Tabletas de acetato de ulipristal.
BRPI0816255A2 (pt) Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
MX2009011869A (es) Aislados antimicrobianos y anti-inflamatorios de extracto de regaliz.
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
CL2011001122A1 (es) Compuestos derivados de carbamatos de alquilheterociclos; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir o tratar dolores agudos o cronicos, patologias neurologicas y psiquiatricas, enfermedades cardiovasculares, entre otras.
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
BRPI0516464B8 (pt) método para a preparação de um produto farmacêutico
UY31662A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de elaboracion.
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina